Cargando…
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer
Data from over 20 years ago demonstrated potential use for insulin-like growth factor (IGF) signaling modulators, specifically with IGF-1R antagonists, in a variety of pediatric and adolescent cancers, particularly in sarcomas. However, in spite of promising preclinical data, IGF-1R inhibitors have...
Autores principales: | Wagner, Michael J., Maki, Robert G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563098/ https://www.ncbi.nlm.nih.gov/pubmed/23383402 http://dx.doi.org/10.3389/fonc.2013.00009 |
Ejemplares similares
-
Hallmarks of cancer: The insulin-like growth factors perspective
por: Werner, Haim, et al.
Publicado: (2022) -
Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells
por: Berk, Şeyda, et al.
Publicado: (2021) -
Insulin-like growth factor binding protein 5: Diverse roles in cancer
por: Waters, Jennifer A., et al.
Publicado: (2022) -
How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor
por: Xu, Yibin, et al.
Publicado: (2022) -
Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk
por: Shi, Joy, et al.
Publicado: (2016)